ANZCCP
Previous
Previous Section
Course Overview
ANZCCP Authorised Prescriber Course
Introduction
Welcome to the ANZCCP AP Course
History of Cannabis
The Endocannabinoid System & Whole Plant Medicine
Main Indications
Chronic Pain
Cancer Pain & Symptoms
Insomnia
Anxiety
PTSD
Epilepsy
Multiple Sclerosis
Safety Considerations
Safety Considerations when Prescribing
Practical Considerations
Practical Considerations when prescribing
Access Pathways
SAS B
Final Test
Final Test
Final Test
Earliest evidence of cannabis cultivation was found in
*
Europe
China
North America
Central America
In which religious scripture is the cannabis plant referred to as a sacred plant
*
Hindu
Judaic
Islamic
None of the above
Cannabis was introduced to western medicine by
*
Queen Victoria
William O’Shaughnessy
Sir William Osler
JFK
1924, Sajous’s Analytic Cyclopedia of Practical Medicine summarized that cannabis was useful in the treatment of
*
Migraines
Tetanus
Rabies
All of the above
Published evidence of the benefits of medical cannabis for the treatment of symptoms of cancer
*
Does not support its use
Is mostly opinion-based
Includes systematic review and meta-analysis
Is of low quality
The most effective way to treat chemotherapy induced nausea and vomiting (CINV) with medical cannabis is
*
High dose oral CBD at the onset of the symptoms
Inhaled flower with appropriate entourage effects prn
Balanced CBD:THC, oral, 2 hours prior to worst nausea periods, titrated to effect
B and C
Terpenes and cannabinoids known to be beneficial for pain include
*
THC, CBD, CBG
Beta-caryophyllene, Myrcene, Linalool
All of the above
None of the above
Published evidence of the benefits of medical cannabis to reduce tumour burden and increase survival rates in cancer
*
Is non-existent
Is limited to murine studies
Is overwhelming
Includes positive data in humans
For patients with multiple sclerosis, there is systematic review and meta-analysis evidence for safety and efficacy relating to
*
Spasticity
Pain
Bladder Dysfunction
All of the above
Medical cannabis’s benefits in patients with Multiple Sclerosis are possibly due to
*
Immune modulation (at least in rodents)
A general decrease in CNS activity, analogous to benzodiazepines
Remyelination
All of the above
A reasonable starting dose for a cannabis naive patient with moderate pain would NOT include which one of the following
*
100mg inhaled tds 20% THC Flower
0.25ml po bd Balanced (10mg/ml THC, 10mg/ml CBD) oil
0.25ml po bd 100mg/ml CBD oil
0.1ml po nocte 25% THC Indica dominant oil
Patients with a history of anxiety or psychosis should generally NOT be prescribed
*
High doses of CBD
THC oils of any sort
Sativa-dominant THC products
Myrcene
Molecules with clinically relevant activity in cannabis include
*
THC and CBD
Cannabinoids
Terpenes
All of the above
Which of the following statements is correct
*
Prescriptions of greater than 30mg THC/day can be supported by AP
Doses of greater than 200mg per day of CBD are required to reduce osteoarthritic pain
THC-containing products consistently cause increased appetite
CBD can ameliorate the psycho-active effects of THC
Which of the following is a symptom of anxiety
*
Feelings of uneasiness
Risk taking
Mania
Fever
Part of the pathophysiology of anxiety disorders is
*
A dysfunctional processing in decision making situations
Overestimation of risk
Inappropriate associations between inappropriate associations between neutral stimuli and danger
All of the above
Which of the following statements regarding the ECS and anxiety is NOT true
*
Endocannabinoid receptors are located throughout the limbic system
CB1 receptor agonists are reported to induce biphasic effects, with lower doses being anxiolytic and higher doses being anxiogenic
The presynaptic release of GABA and glutamate, is affected by CB1 receptor activation
The activation of GABA release by CB1 activation seems to be the cause of the anxiogenic- responses to a high dose of cannabinoids
Which of the following statements regarding phytocannabinoids and anxiety is true
*
There is no association between cannabis use and anxiety
Cannabis has been used across most ancient civilizations for its medicinal, relaxing and mood-enhancing properties
CBD has antagonist properties at the serotonergic 5-HT1A receptor
THC is never effective in reducing anxiety
The four clusters of PTSD symptoms are
*
Intrusions, Avoidance, Negative alterations in cognition and mood, Alterations in arousal and reactivity
Intrusions, Panic, Stress, Depression
Avoidance, Inclusions, Cognitive dysfunction, sleep disorders
Depression, Anxiety, Sleep disorders, Daytime arousal
Which of the following best describes the treatment options with cannabis for PTSD
*
Medicinal cannabis can not play a significant role in the management of PTSD
The is no role for the modulation of the ECS in management of PTSD
ECB signalling enhancement by phytocannabionids from medicinal cannabis reduce reactivity of the amygdala
Only THC showed significant benefit in the treatment of PTSD
Regarding the ECS and PTSD, which of the following statements is incorrect
*
The ECS plays an important role in the modulation of the physiologic and behavioural response to stress exposure
The ECS modulates the activation and termination of the HPA-axis function in response to stress
Acute and repeated stress exposure increases AEA levels in limbic regions including the amygdala, PFC, hippocampus, and hypothalamus
Stress exposure causes CRH release, which in turn increases FAAH activity to drive down AEA levels within cortico-limbic structures
Which of the following statements have not been shown to be an outcome of the use of phytocannabionoids in PTSD
*
Anxiety reduction
Suppress of the recall and enhancement of extinction of emotionally aversive memories
Reduction of time spent sleeping
Dampening of inflammatory processes
Regarding the role of the ECS in insomnia, the following is true
*
Inhibiting the catabolism of endocannabinoids by enzyme blockage has been shown to increase non-REM sleep and regulate sleep stability in animal models
There is no association between the ECS and circadian rhythm
ECS function does not show diurnal variation
It is largely cannabinoid receptor 2 (CB2) that contributes to modulating sleep and circadian cycles
Regarding conventional management of insomnia, the following statement is true
*
Pharmacological intervention is first line treatment of insomnia
There is no specific psychological intervention available for the treatment of insomnia
Selecting the right medication is dependent on the type of insomnia symptoms
There is no role for non-pharmacological management
Regarding THC and sleep disorders, the following statement is incorrect
*
THC and its sedative and muscle-relaxant properties have been extensively discussed by leading cannabinoid researchers
THC acts as an antagonist on CB1 receptors in the central nervous system and brain
It is hypothesised CB1 activation induces sedation via increasing acetylcholine release in areas of the brain associated with sleep
Human research has indicated acute THC administration improves sleep onset latency, decreases waking, increasing non-REM sleep and decreasing REM sleep
The most evidence from recent clinical trials for treatment options with medicinal cannabis for insomnia exist for
*
Combinations of THC and CBD
THC only
CBD only
Topical CBD
Regarding toxicity of medicinal cannabis, the following statement is correct
*
Medicinal cannabis has high level of toxicity
Toxicity of THC is very low compared to most other recreational and pharmaceutical drugs
High doses and concurrent use of other drugs will not mask the effect of cannabis and will not increase the likelihood of adverse events
It is quite realistic that a 70kg person could consume a lethal dose of cannabis
Which of the following is not a known side effect of cannabidiol
*
Somnolence
Hallucinations
Diarrhea
Transaminase elevations
Regarding cannabidiol (CBD) drug interactions which of the following is incorrect
*
CBD does not have any significant interactions with other medications
CBD is an inhibitor of several CYP450
CBD is an inhibitor of several UGT enzymes
CBD can be administered with other medications
The following statement is true
*
There are no contraindications for the use of medicinal cannabis
Pure cannabis can be smoked with no detrimental health effects
Medicinal cannabis can never be used in patients with a history of CVD
Patients with history of schizophrenia can be prescribed with CBD
Cannabis medicines are NOT
*
Effective at controlling acute pain
Effective at controlling chronic pain
Safe to use in inflammatory pain
All of the above
THC… (choose incorrect option)
*
Should generally always be used in conjunction with CBD
Is the principle nociceptive compound in cannabis medicines
Has nociceptive activity primarily via anti-inflammatory effects
May induce somnolence
Cannabis interacts with opioids… (choose incorrect option)
*
THC and opiates create a synergistic analgesic effect when used concurrently, known as the "opioid sparing effect"
Cannabis and opioid medications should not be used conjunctly, though can be given if separated in time by 2 hours or greater
THC stimulates release of endogenous opioids via stimulation of delta and kappa opioid receptors
THC, CBD and opioids when used together, often results in reduction of opiate dose and reduced chance of respiratory depression
A 65 year old woman presents with spinal degeneration and neuropathic pain, which of the following would NOT be a reasonable initial choice of medicines
*
Oral preparation 10mg THC/mL and 10mg CBD/mL- starting dose 0.2mL TDS titrating to pain tolerance
Oral preparation 25mg THC/mL – starting dose 0.2mL BD titrating to pain tolerance
Oral CBD 10mg/mL- 20-30mg BD + Oral THC 25mg/mL- starting at 0.1mL BD and titrating to pain tolerance
Inhaled cannabis indica flower – 0.1-0.25g BD prn
Choose the incorrect statement below
*
High prevalence of cannabinoid receptors in the respiratory centres of the brainstem mean respiratory suppression via overdose of THC is not possible
Onset of action of inhaled cannabis is less than 5 minutes, with an approximate duration of 2-4hrs, so it is useful for treatment of breakthrough pain
CBD should always be used in conjunction with THC
Onset of action of oral/ sublingual cannabis is approximately 1hour, with an approximate duration of 8hrs, so it is suitable as a regular long acting nociceptive medicine
Choose the incorrect statement
*
THC is the principle cannabinoid and binds orthsterically to cannabis receptors
THC is responsible for the psychoactive effects of cannabis
Cannabis medicines are generally well tolerated, and can not cause mortality via overdose
CBD is the main pain relieving cannabinoid
Choose the incorrect statement
*
The cannabis plant is composed of many bioactive molecules, with (potentially) over 144 cannabinoids, and over 400 terpenes combining in a synergistically in what is coined “the entourage effect”
Isolated or purified CBD and THC more efficacious than whole plant cannabis extracts, as the isolated molecules have uninterrupted binding to cannabis receptors
Terpenes such as myrcene, linalool and beta caryophyllene, are commonly found in “indica” varieties of cannabis
CBD is an excellent anxiolytic molecule, and reduces negative psychoactive effects of THC. CBD should always be used in conjunction with THC
Choose the incorrect option
*
CBD inhibits FAAH, resulting in extended action of anandamide and activates 5HT1A receptors resulting in increased levels of dopamine and serotonin
CBD is neuroprotective and anti-inflammatory
CBD may antagonize CYP450 enzyme activity in the liver, usually at higher doses
Low doses of CBD are necessary due to potential neurotoxic effects associated with CBD use- doses of 30mg daily should not be exceeded
In regards to the ECS (endocannabinoid system) please choose the incorrect answer
*
The ECS is a discreet closed system of vessels that regulates activation of all other bodily systems
The ECS is an homeostatic, regulatory system influencing multiple physiological systems. Its aim is the maintenance of a stable internal bodily environment
Retrograde inhibition is a term that indicates the inhibitory effect of cannabinoid receptor stimulation on presynaptic receptor neurotransmitter release
CB1R are located mainly in the CNS. CB2R are mainly located peripherally and are associated with immune and inflammatory physiological response
Regarding epilepsy please choose the incorrect answer
*
All types of epilepsy may be amenable to treatment with cannabis medicines, and CBD is a mainstay of treatment
CBD may interact in an antagonist way with CYP450 at higher doses (consider this at doses greater than 80mg CBD daily)
CBD treatment may take some time to take effect, and higher doses of CBD may be required to get anti seizure effect
Isolated CBD is a good choice for epileptic patients as larger doses of CBD may be used
Drugs which are commonly effected by high doses of CBD and its interaction with CYP450 include…
*
Clobazam
Phenytoin
Apixaban
All of the above
When dosing cannabis medicines for epilepsy… (choose incorrect option)
*
CBD in a 20:1 ratio (CBD:THC) seems effective, titrating to effect with an approximate max dose of 15mg CBD/kg
Concurrent ailments/ symptoms should be treated symptomatically with THC where appropriate- eg sleep/ pain insomnia
Patients will respond individually to different chemovars. Minor cannabinoids and terpene variations between chemovars may, so changing between chemovars may be useful in treating epileptic patients
All conventional medications should be discontinued prior to commencement of cannabinoid medications
A 32 year old female presents with long standing, treatment resistant epilepsy, which of the following is not a reasonable way to commence treatment for the patient
*
CBD full spectrum 100mg/mL – 0.5mL BD / TDS
CBD isolated 100mg/mL – 0.5mL BD / TDS
Inhaled “balanced” mid strength flower- 10mgcbd + 10mg THC/g- 0.2-0.5g BD vapourized
CBD full spectrum 100mg/mL – 0.5mL BD / TDS + THC full spectrum 25mg/mL- 0.1-0.8mL nocte